No Picture
Industry News

Immune therapy developed through Sanford Burnham Prebys and Lilly collaboration enters Phase 1 clinical trial

Sanford Burnham Prebys Medical Discovery Institute (SBP) today announced that the first healthy subject has been dosed in a Phase 1 clinical trial evaluating LY3361237, a biologic that inhibits inflammation by activating an immune checkpoint receptor. […]

No Picture
Industry News

Meeting the ?man who saved my son?s life?

?I?ve got really cool stuff in my body,? 6-year-old Baraa Ismail proclaimed to Hudson Freeze, Ph.D., professor in the Human Genetics program at Sanford Burnham Prebys Medical Discovery Institute (SBP).

And, indeed, he does.?

Baraa and his mother, Sar… […]